Marie A. Lindner, MD Joins Plexus Ventures

Marie A. Lindner, M.D. joins Plexus Ventures

PHILADELPHIA, PA, April 2007 — Plexus Ventures, an entrepreneurial global pharmaceutical business development firm, is pleased to welcome Marie A. Lindner, M.D. as Senior Consultant and a member of the Plexus team. Dr. Lindner brings an array of new and complementary skills and experience to Plexus in clinical development, regulatory affairs, business development, manufacturing and process development, intellectual property management and global operations. Dr. Lindner has extensive experience with development-stage companies (Isolagen, Orphagenix and Embera NeuroTherapeutics), a technology transfer firm (BTG International) and with global pharmaceutical firms (SmithKline Beecham and Rhône-Poulenc Rorer).

“We’re delighted to welcome Dr. Marie Lindner to the Plexus team,” noted Plexus Ventures President, Bob Moran. “Marie has the clinician’s perspective we were lacking as well as a wonderful experience in both the biotech and pharmaceutical industries. Dr. Lindner also possesses significant business development experience and expertise.”

Marie Lindner earned her medical degree at the Chicago Medical School/University of Health Sciences. She is Board Certified in Clinical Nutrition and Internal Medicine. From 1991 through 1998, Dr. Lindner worked at Rhone-Poulenc Rorer (now Sanofi-Aventis) where she held many positions ranging from Assistant Director of Clinical Development to Executive Director, Business Development and Licensing. During her time at RPR, Marie spent four years at Gencell, RPR's gene and cell therapy division. In 1998, Dr. Lindner joined SmithKlineBeecham (now GlaxoSmithKline) where she served as Global Director of Business Development. In 2000, Dr. Lindner joined Elan as Vice President of Medical Market Strategy in the Drug Delivery division. She was named Vice President, Strategic Business Development at BTG in 2003. In recent years, Dr. Lindner’s entrepreneurial skills have benefited development-stage companies.

About Plexus Ventures
Plexus Ventures, founded in 1990, provides strategic advice, business development and alliance management services to clients in the pharmaceutical, biotechnology and drug delivery industries worldwide. Plexus Ventures assists its clients in the areas of in-licensing, out-licensing, acquisitions, divestitures and strategic partnerships. With offices in London, Los Angeles, Milan, Philadelphia, Tokyo and Warsaw, Plexus Ventures possesses the capabilities to effectively serve clients in the United States, Europe and Asia. Plexus Ventures is both well-known and well respected by leading research-based pharmaceutical companies worldwide. For further information, please consult http://www.plexusventures.com.

For More Information, Contact:
Mary Alice Strong
mas@plexusventures.com
+1-310-315-7106